Delivery Order SPM20005D3404-EQ74
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major pharmaceutical and medical supply distributor. The $115,940.37 firm fixed-price contract is for the provision of TRICARE West medical supplies, including prescription medications, vaccines, and other consumables. Cardinal Health has a long history of providing pharmaceutical distribution services to the U.S. Department of Defense, Department of Veterans Affairs, and National...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $3,814.82, is for the provision of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH) under the DLA's Pharmaceutical Prime Vendor program. Cardinal Health, which has been a federal contractor since 2001,...
- This federal contract award is a delivery order for $80,694.19 from the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract is for the provision of pharmaceutical and medical supplies to the Department of Defense (DoD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH). Cardinal Health has a long-standing relationship with the federal government, having been registered to receive awards since 2001....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $2,126.88, is for the provision of pharmaceutical and medical supplies to the U.S. government, primarily the Department of Defense (DOD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH). Cardinal Health has a long-standing relationship with the government, having held federal contracts...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract is for $96,092.69 and is for the provision of TRICARE medical supplies and pharmaceuticals to the DLA. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating that Cardinal Health, Inc. was selected as the prime contractor based on its capabilities and experience in serving as a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $1,760.09, is for the provision of pharmaceutical and medical supplies to the DLA's Medical Supply Chain program, which serves the Department of Defense (DoD) and other federal agencies. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating Cardinal Health's ability to compete...
- The U.S. government, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $9,021.90, is for the provision of pharmaceutical and medical supplies to the federal government, including the Department of Defense (DOD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH). This delivery order is part of the DLA's Pharmaceutical Prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services company. The contract, valued at $2,873.59, is for the provision of pharmaceutical and medical products to support the DLA's Pharmaceutical Prime Vendor program. This program supplies a comprehensive range of medical products, including prescription medications, vaccines, and radiopharmaceuticals, to military treatment facilities and deployed troops...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, for $1,676.32. The contract is to provide pharmaceutical and medical supplies to the DLA's Medical Supply Chain program, which supports the Department of Defense (DoD) and other federal agencies. The contract does not have a set-aside designation, indicating that Cardinal Health, Inc. was able to compete for the award on an...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $154,571.27 contract is for the supply of a wide range of pharmaceutical and medical products, including prescription medications, over-the-counter drugs, vaccines, and radiopharmaceuticals, to support the TRICARE West program. Cardinal Health has a long-standing relationship with the federal government, providing distribution...
- SPM20005D3404Indefinite Delivery Contract
- SPM20005D3404-EQ74Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $115,963.27, is for the provision of TRICARE pharmaceutical products and medical supplies to the DLA. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Cardinal Health's status as a large, for-profit corporation. Cardinal Health has a long-standing relationship with government procurement, having been registered to receive federal awards since June 2001. The company is a major supplier of pharmaceutical and medical products to various government agencies, including the Department of Defense (DoD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH). In addition to this delivery order, Cardinal Health also holds a significant indefinite delivery contract (IDC) with the VA for the supply of radiopharmaceutical products used in medical imaging procedures within the VA healthcare system. The company's subsidiary, The Harvard Drug Group, L.L.C., has also secured a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.0k | 5/11/15 |